“We Got Funded!” KSA-Based Aumet Raises US$12 Million Series A to Scale AI-Powered Health Procurement Across GCC

Aumet, a KSA-headquartered AI-powered procurement operating system for healthcare, has raised US$12 million in a Series A funding round led by Riyadh-based Emkan Capital.

Other participants included Qatar Development Bank, Azerbaijan-based SABAH VC, and Singapore-based AAIC, alongside existing investor Shorooq, an Abu Dhabi-based multi-strategy investment firm.

The funding will support Aumet’s expansion across global healthcare systems, with a focus on scaling enterprise deployments in the GCC, particularly Saudi Arabia.

Founded in 2016 by Yahya Aqel, chief executive officer, and Adel Haddad, chief strategy officer, Aumet connects pharmacies, hospitals, suppliers, and healthcare systems into a single procurement network.

“Over the next 12 months, our focus will be on accelerating product innovation, strengthening our AI procurement infrastructure, and expanding aggressively across key markets, especially Saudi Arabia,” Aqel shared. “A significant part of the funding will go into AI engineering, enterprise healthcare solutions, and scaling our marketplace and pharmacy operating system globally.”

He added that Aumet is investing in automation and AI capabilities to improve operational efficiency, and is planning to expand its teams across technology, enterprise sales, and customer success as it scales its operations.

With the funding, Aumet will be developing  AI tools including demand forecasting for hospitals and pharmacies, procurement recommendation systems, inventory optimization and anomaly detection systems, supplier matching tools and automated purchasing workflows. It is also building tools to help pharmacies reduce dead stock and improve margins.

“Our goal is to make procurement faster, smarter, and more autonomous. We believe healthcare supply chains globally still operate with massive inefficiencies, and AI can fundamentally transform how medicines and medical supplies move across the ecosystem,” Aqel said.

Meanwhile, Haddad shared Saudi Arabia is one of the company’s top strategic priorities, citing market potential driven by healthcare transformation under Vision 2030.

“Our roadmap includes scaling our pharmacy operating system, expanding our marketplace network, and increasing our enterprise footprint with hospitals and large healthcare groups. We are also localizing our products and integrations to fit the operational and regulatory requirements of the Saudi market,” Haddad said.

He added that Aumet is expanding across the GCC and preparing for international growth, including potential entry into Europe and other markets.

Aumet has processed more than US$1 billion in gross merchandise value, facilitated over 5 million transactions annually, and connected more than 12,000 pharmacies with over 1,000 pharmaceutical suppliers across Jordan, Egypt, and Saudi Arabia. Its platform has been deployed across 32 hospitals, more than 500 medical centers, and 18 medical warehouses, including within public healthcare systems.

The company  is also working with Presight, a G42 company, to expand its AI procurement platform across public healthcare networks in the UAE.

TREP TALK: Yahya Aqel, CEO and co-founder of Aumet, on scaling digital health platforms in the Middle East

Build for reality, not abstraction “Solve a real operational problem, not just a technology problem. Build products that can operate in fragmented and complex regulatory environments. Focus deeply on trust and relationships, especially in healthcare.”

Scale through execution and intelligence “Prioritize execution speed and adaptability over perfection. Invest early in data and AI capabilities because they will become a major competitive advantage in healthcare.”